XORTX Therapeutics Inc. is a pharmaceutical company developing products targeting aberrant purine metabolism and xanthine oxidase to decrease or inhibit uric acid production. It serves patients with conditions such as Autosomal Dominant Polycystic Kidney Disease, Coronavirus/COVID-19 infection, and Type 2 Diabetic Nephropathy.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.